Synthesized peptide derived from the N-terminal region of human Cdc42EP5.
Conjugate
Unconjugated
Applications
Application Notes
WB: 1:500-1:2000 IHC: 1:100-1:300 ELISA: 1:40000
General Notes
This product (Catalog No. CABT-BL1019) is a rabbit-derived polyclonal antibody raised against human CDC42EP5. This antibody exhibits cross-reactivity with CDC42EP5 from mouse. It has been affinity purified by Protein A. Cell division control protein 42 (CDC42), a small Rho GTPase, regulates the formation of F-actin-containing structures through its interaction with the downstream effector proteins. The protein encoded by this gene is a member of the Borg (binder of Rho GTPases) family of CDC42 effector proteins. Borg family proteins contain a CRIB (Cdc42/Rac interactive-binding) domain. They bind to CDC42 and regulate its function negatively. The encoded protein may inhibit c-Jun N-terminal kinase (JNK) independently of CDC42 binding. The protein may also play a role in septin organization and inducing pseudopodia formation in fibroblasts. CABT-BL1019 is suitable for use in Western blot (WB) (1:500–1:2,000), IHC (1:100–1:300), ELISA (1:40000) applications. CABT-BL1019 is supplied as a liquid formulation in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.
Target
Alternative Names
CDC42EP5; BORG3; CEP5; Cdc42 effector protein 5; Binder of Rho GTPases 3
My Review for Rabbit Anti-Human Cdc42EP5 (N-terminal) Polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.